piracetam has been researched along with seletracetam in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamann, M; Richter, A; Sander, SE | 1 |
Bonsi, P; Cuomo, D; Madeo, G; Martella, G; Pisani, A; Platania, P; Sciamanna, G; Tassone, A | 1 |
Frycia, A; Jadot, S; Kenda, B; Lallemand, B; Leclercq, K; Lo Brutto, P; Matagne, A; Mercier, J; Starck, JP; Verbois, V | 1 |
Kleinebudde, P; Kuntz, T; Schubert, MA | 1 |
4 other study(ies) available for piracetam and seletracetam
Article | Year |
---|---|
Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Topics: Animals; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Severity of Illness Index | 2008 |
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Biophysics; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; GABA Antagonists; In Vitro Techniques; Levetiracetam; Magnesium; Male; Membrane Potentials; Neocortex; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Pyrrolidinones; Rats; Rats, Wistar | 2009 |
Discovery of indolone acetamides as novel SV2A ligands with improved potency toward seizure suppression.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Indoles; Levetiracetam; Ligands; Membrane Glycoproteins; Mice; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Rats; Seizures; Synaptic Vesicles | 2010 |
Increased compactibility of acetames after roll compaction.
Topics: Central Nervous System Agents; Chemical Phenomena; Drug Compounding; Levetiracetam; Particle Size; Piracetam; Powders; Pressure; Pyrrolidinones; Surface Properties; Tablets | 2011 |